Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewImmunologyOncology Open Access | 10.1172/JCI193945

IL-17-producing γδ T cells in the tumor microenvironment promote radioresistance in mice

Yue Deng,1 Xixi Liu,1 Xiao Yang,1 Wenwen Wei,1 Jiacheng Wang,1 Zheng Yang,1 Yajie Sun,1 Yan Hu,1 Haibo Zhang,2 Yijun Wang,1 Zhanjie Zhang,1 Lu Wen,1 Fang Huang,1 Kunyu Yang,1 and Chao Wan1

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Deng, Y. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Liu, X. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Yang, X. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Wei, W. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Wang, J. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Yang, Z. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Sun, Y. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Hu, Y. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Zhang, H. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Wang, Y. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Zhang, Z. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Wen, L. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Huang, F. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Yang, K. in: PubMed | Google Scholar

1Cancer Center, Huazhong University of Science and Technology, Wuhan, China

2Department of Radiation Oncology, Hangzhou Medical College, Hangzhou, China

Find articles by Wan, C. in: PubMed | Google Scholar |

Published October 7, 2025 - More info

J Clin Invest. https://doi.org/10.1172/JCI193945.
Copyright © 2025, Deng et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published October 7, 2025 - Version history
View PDF
Abstract

The immunosuppressive tumor microenvironment (TME) drives radioresistance, but the role of γδ T cells in regulating radiosensitivity remains incompletely understood. In this study, we found that γδ T cell infiltration in the TME substantially increased after radiotherapy and contributed to radioresistance. Depletion of γδ T cells enhanced radiosensitivity. Single-cell RNA sequencing revealed that γδ T cells in the post-radiotherapy TME were characterized by the expression of Zbtb16, Il23r, and Il17a, and served as the primary source of IL-17A. These γδ T cells promoted radioresistance by recruiting myeloid-derived suppressor cells and suppressing T cell activation. Mechanistically, radiotherapy-induced tumor cell-derived microparticles containing dsDNA activated the cGAS-STING/NF-κB signaling pathway in macrophages, upregulating the expression of the chemokine CCL20, which was critical for γδ T cell recruitment. Targeting γδ T cells and IL-17A enhanced radiosensitivity and improved the efficacy of radiotherapy combined with anti-PD-1 immunotherapy, providing potential therapeutic strategies to overcome radioresistance.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (October 7, 2025): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts